Please assess the completion status of the following clinical trial:

Trial Title: A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of a hemato-oncological disorder~* Scheduled to undergo a lumbar puncture~* Aged 4-11 years~* Male or female~* Unpremedicated~* Willing and able to provide informed consent (or informed consent by parents)~Exclusion Criteria:~* Children who are known or suspected to be difficult to ventilate by face mask~* Children who are deemed medically unfit to receive either of the two study medications~* Children who are obese (weight for height \> 95th percentile,~* Children who do not have an indwelling intravenous line

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Propofol 4 mg/kg group (Type: EXPERIMENTAL): First patient in this arm will receive a bolus of propofol 4 mg/kg followed by remifentanil 0.5 mcg/kg. Subsequent patients randomized to this arm will receive propofol 4 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)
- Propofol 2 mg/kg group (Type: EXPERIMENTAL): First patient in this arm will receive a bolus of propofol 2 mg/kg followed by remifentanil 1 mcg/kg. Subsequent patients randomized to this arm will receive propofol 2 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)

Based on this trial design, predict the completion outcome and termination type (if applicable).